Perspectives
Check out the new Prime/MRx GLP-1 Strategy page
March 14, 2024After the release of its industry-leading research on GLP-1a drugs for weight loss in July 2023, Prime Therapeutics/Magellan Rx Management (Prime/MRx) continues to shape the narrative on this dynamic trend.
We’ve compiled all of our GLP-1 resources and thought leadership onto a new GLP-1 Strategy page, including our research, podcasts, videos, recent articles and more. Our aim is to highlight our evidence-based approach to GLP-1 drugs, working with our partners to develop individualized strategies that promote clinically appropriate use and consider total cost of care, long-term value, and member health outcomes.
For more, check back for regular updates on our Prime News site.
And to get the latest news and insights from Prime/MRx, sign-up for our twice-a-month newsletter, Prime Post.
Related news
Perspectives
July 25, 2024
Quarterly Drug Pipeline: July 2024
Clinical insights and competitive intelligence on anticipated drugs in development
Perspectives
July 22, 2024
Oncology Insights: 2024 ASCO Annual Meeting key findings
Findings from this year’s American Society of Clinical Oncology (ASCO) Annual Meeting will likely lead to clinical practice changes and U.S. Food and Drug Administration (FDA) drug approvals or expansions
Perspectives
July 16, 2024
LISTEN NOW: Beyond the business – Stories of corporate kindness | Pharmacy Friends Podcast
In this episode, we talk about how our employees' help goes beyond our work in health care, aiding in philanthropic efforts